查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲核酸樣品製備市場分析與預測：2022-2032
市場調查報告書
商品編碼
1382599

歐洲核酸樣品製備市場分析與預測：2022-2032

Europe Nucleic Acid Sample Preparation Market - Analysis and Forecast, 2022-2032
出版日期: | 出版商: BIS Research | 英文 107 Pages | 商品交期: 1-5個工作天內

價格

歐洲核酸樣品製備市場規模預計將從 2022 年的 13.074 億美元成長到 2032 年的 33.567 億美元，預測期內年複合成長率為 9.89%。

核酸分子在各個醫學領域的使用機會的增加預計將推動歐洲核酸樣品製備市場的成長。此外，該地區的核酸樣品製備市場正在擴大，這主要是由於對次世代定序（NGS）等下游應用以及與核酸萃取/分離技術相關的其他發展的需求不斷成長所推動。

對快速診斷資訊和有針對性的患者治療的需求不斷成長也推動了市場的成長。為了滿足這項需求，已經開發了多種分子程序，包括自動化核酸樣品製備工作站。此外，樣品製備在精準醫療中發揮重要作用，確保個體化治療的可靠和有效應用。

本報告調查了歐洲核酸樣品製備市場，並提供了市場概況，分析了市場成長的各種影響因素、法律制度、市場規模趨勢和預測，以及各個細分市場、地區和主要國家的詳細分析。,競爭形勢、主要企業分析等

主要市場統計數據
預測期 2022-2032
2022年評估 13.074 億美元
2032年預測 33.567 億美元
年複合成長率 9.89%

市場區隔

細分 1：按國家/地區

  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 英國
  • 歐洲其他地區

目錄

第1章 市場

  • 產品定義
  • 市場範圍
  • 調查方法
  • 市場概況
    • 市場定義
    • 市場規模/成長潛力
  • 潛在市場規模/成長潛力
    • 歐洲
  • 參加企業形勢

第2章 核酸樣品製備市場：產業分析

  • 業界考察
    • 歐洲法律要求和框架
  • 專利分析
  • COVID-19對核酸樣本製備市場的影響

第3章 核酸樣品製備市場：市場動態

  • 概述
  • 市場促進因素
    • 核酸分子在各個治療領域的應用不斷增加
    • 核酸萃取分離技術進展
    • 自動化樣品製備工作站的優點
    • 次世代定序(NGS) 等下游應用的需求不斷增加
  • 市場抑制因素
    • 自動化工作站高成本
    • 嚴格的法規標準
  • 市場機會
    • 自動化樣品製備工作站的技術進步
    • 用於生物樣本庫的核酸分子
    • 新興國家的成長

第4章 競爭形勢

  • 概述
  • 企業策略
  • 經營策略
  • 市場佔有率分析

第5章 核酸樣品製備市場：依地區

  • 概述
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第6章 公司簡介

  • Endress+Hauser Group Services AG (Analytik Jena GmbH)
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • QIAGEN
  • Tecan Trading AG
Product Code: BHP1512SS

“The Europe Nucleic Acid Sample Preparation Market Expected to Reach $3,356.7 Million by 2032.”

Introduction to Europe Nucleic Acid Sample Preparation Market

The Europe nucleic acid sample preparation market is projected to reach $3,356.7 million by 2032 from $1,307.4 million in 2022, growing at a CAGR of 9.89% during the forecast period 2022-2032. The increased use of nucleic acid molecules in a variety of medicinal contexts is expected to fuel the growth of the nucleic acid sample preparation market in Europe. Furthermore, the region's nucleic acid sample preparation market is expanding due in large part to the increased demand for downstream applications such as next-generation sequencing (NGS) and other associated developments in nucleic acid extraction/isolation techniques.

KEY MARKET STATISTICS
Forecast Period2022 - 2032
2022 Evaluation$1,307.4 Million
2032 Forecast$3,356.7 Million
CAGR9.89%

Market Introduction

The nucleic acid sample preparation market in Europe is currently advancing to meet the increasing demand for prompt diagnostic information and targeted patient treatment. Various molecular procedures, including automated nucleic acid sample preparation workstations, have been developed to address this need. Furthermore, sample preparation plays a crucial role in precision medicine, ensuring the secure and effective application of personalized therapies. The market provides a diverse range of universal products with varying maximum throughputs, innovations, time durations, and other attributes, prompting companies to explore inventive ways to differentiate themselves. Notably, manufacturers have recently introduced application-specific nucleic acid purification devices and liquid handlers to cater to specific needs in the European market.

Impact

One of the main reasons for the anticipated expansion of the nucleic acid sample preparation market in the upcoming years is the rise in the use of nucleic acid molecules in several therapeutic areas. Sample preparation is typically an important phase in the accurate analysis of nucleic acids. Nuclease protection is one of the most important aspects to consider while processing nucleic acid samples. Nucleic acid extraction and isolation is the first stage in the area of molecular biology research, followed by recombinant procedures.

Market Segmentation:

Segmentation 1: by Country

  • Germany
  • France
  • Italy
  • Spain
  • U.K.
  • Rest-of-Europe

In 2021, Europe accounted for a share of 31.14% of the nucleic acid sample preparation market. The presence of some of the prominent companies in the market is a key factor driving the growth of the Europe region.

Recent Developments in the Europe Nucleic Acid Sample Preparation Market

  • In November 2022, RevoluGen, a U.K.-based genomics company, announced that it had entered into an agreement with Tecan Trading AG, a pioneer and industry leader in laboratory automated processes, for the production and supply of Tecan's 96-well filter plates for use in RevoluGen's automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.

How can this report add value to an organization?

Growth/Marketing Strategy: Nucleic acid sample preparation is being used for genomics, proteomics, and other applications. Various companies are providing consumables and systems aid in the diagnosis of various therapeutic areas, which is also the key strategy for market players to excel in the current Europe nucleic acid sample preparation market.

Competitive Strategy: Key players in the Europe nucleic acid sample preparation market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe nucleic acid sample preparation market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

  • Endress+Hauser Group Services AG
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • QIAGEN
  • Tecan Trading AG

Table of Contents

1 Market

  • 1.1 Product Definition
    • 1.1.1 Inclusion and Exclusion Criteria
  • 1.2 Market Scope
    • 1.2.1 Scope of the Study
    • 1.2.2 Key Questions Answered in the Report
  • 1.3 Research Methodology
    • 1.3.1 Nucleic Acid Sample Preparation Market: Research Methodology
    • 1.3.2 Data Sources
      • 1.3.2.1 Primary Data Sources
      • 1.3.2.2 Secondary Data Sources
    • 1.3.3 Market Estimation Model
    • 1.3.4 Criteria for Company Profiling
  • 1.4 Market Overview
    • 1.4.1 Market Definition
    • 1.4.2 Market Footprint and Growth Potential, $Million, 2021-2032
  • 1.5 Addressable Market Size and Growth Potential ($Million), 2021-2032
    • 1.5.1 Europe
  • 1.6 Industry Participants Landscape

2 Nucleic Acid Sample Preparation Market, Industry Analysis

  • 2.1 Industry Insights
    • 2.1.1 Legal Requirements and Framework in Europe
  • 2.2 Patent Analysis
    • 2.2.1 Patent Filing Trend
    • 2.2.2 Patent Analysis (by Year)
    • 2.2.3 Patent Analysis (by Country)
    • 2.2.4 Patent Analysis (by Region)
  • 2.3 Impact of COVID-19 on the Nucleic Acid Sample Preparation Market

3 Nucleic Acid Sample Preparation Market: Market Dynamics

  • 3.1 Overview
  • 3.2 Market Drivers
    • 3.2.1 Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
    • 3.2.2 Advancement in the Nucleic Acid Extraction/Isolation Techniques
    • 3.2.3 Advantages of Automated Sample Preparation Workstations
    • 3.2.4 Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)
  • 3.3 Market Restraints
    • 3.3.1 High Cost of Automated Workstations
    • 3.3.2 Rigid Regulatory Standards
  • 3.4 Market Opportunities
    • 3.4.1 Technological Advancements in Automated Sample Preparation Workstations
    • 3.4.2 Nucleic Acid Molecules for Biobanking in Healthcare
    • 3.4.3 Growth in Emerging Nations

4 Competitive Landscape

  • 4.1 Overview
  • 4.2 Corporate Strategies
    • 4.2.1 Mergers and Acquisitions
    • 4.2.2 Synergistic Activities
    • 4.2.3 Business Expansions
  • 4.3 Business Strategies
    • 4.3.1 Product Launches
  • 4.4 Market Share Analysis

5 Nucleic Acid Sample Preparation Market, by Region ($Million), 2021-2032

  • 5.1 Overview
  • 5.2 Europe
    • 5.2.1 Germany
    • 5.2.2 France
    • 5.2.3 U.K.
    • 5.2.4 Italy
    • 5.2.5 Spain
    • 5.2.6 Rest-of-Europe

6 Company Profiles

  • 6.1 Overview
  • 6.2 Endress+Hauser Group Services AG (Analytik Jena GmbH)
    • 6.2.1 Company Overview
    • 6.2.2 Role of Endress+Hauser Group Services AG (Analytik Jena GmbH) in the Global Nucleic Acid Sample Preparation Market
    • 6.2.3 Key Customers of the Company
    • 6.2.4 Key Competitors of the Company
    • 6.2.5 Business Strategies
    • 6.2.6 Financials
    • 6.2.7 Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Region), $Million, 2019-2021
    • 6.2.8 Key Insights about the Financial Health of the Company
    • 6.2.9 Analyst Perspective
  • 6.3 Eppendorf SE
    • 6.3.1 Company Overview
    • 6.3.2 Role of Eppendorf SE in the Nucleic Acid Sample Preparation Market
    • 6.3.3 Key Competitors of the Company
    • 6.3.4 Financials
    • 6.3.5 Key Insights about the Financial Health of the Company
    • 6.3.6 Analyst Perspective
  • 6.4 F. Hoffmann-La Roche Ltd
    • 6.4.1 Company Overview
    • 6.4.2 Role of F. Hoffmann-La Roche Ltd in the Nucleic Acid Sample Preparation Market
    • 6.4.3 Key Competitors of the Company
    • 6.4.4 Business Strategies
    • 6.4.5 Financials
    • 6.4.6 Key Insights about the Financial Health of the Company
    • 6.4.7 Analyst Perspective
  • 6.5 Merck KGaA
    • 6.5.1 Company Overview
    • 6.5.2 Role of Merck KGaA in the Nucleic Acid Sample Preparation Market
    • 6.5.3 Key Competitors of the Company
    • 6.5.4 Financials
    • 6.5.5 Key Insights about the Financial Health of the Company
    • 6.5.6 Analyst Perspective
  • 6.6 QIAGEN
    • 6.6.1 Company Overview
    • 6.6.2 Role of QIAGEN in the Nucleic Acid Sample Preparation Market
    • 6.6.3 Key Customers of the Company
    • 6.6.4 Key Competitors of the Company
    • 6.6.5 Business Strategies
    • 6.6.6 Financials
    • 6.6.7 Key Insights about the Financial Health of the Company
    • 6.6.8 Analyst Perspective
  • 6.7 Tecan Trading AG
    • 6.7.1 Company Overview
    • 6.7.2 Role of Tecan Trading AG in the Nucleic Acid Sample Preparation Market
    • 6.7.3 Key Customers of the Company
    • 6.7.4 Key Competitors of the Company
    • 6.7.5 Financials
    • 6.7.6 Key Insights about the Financial Health of the Company
    • 6.7.7 Analyst Perspective

List of Figures

  • Figure 1: Nucleic Acid Sample Preparation Market, $Million, 2021 and 2032
  • Figure 2: Nucleic Acid Sample Preparation Market Segmentation
  • Figure 3: Share of Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
  • Figure 4: Share of Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
  • Figure 5: Share of Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
  • Figure 6: Share of Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
  • Figure 7: Share of Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
  • Figure 8: Share of Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
  • Figure 9: Nucleic Acid Sample Preparation Market (by Region)
  • Figure 10: Nucleic Acid Sample Preparation Market Segmentation
  • Figure 11: Nucleic Acid Sample Preparation Market: Research Methodology
  • Figure 12: Primary Research Methodology
  • Figure 13: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 14: Top-Down Approach (Segment-Wise Analysis)
  • Figure 15: Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 16: Europe Nucleic Acid Sample Preparation Addressable Market, 2021-2032
  • Figure 17: Nucleic Acid Sample Preparation Market, Patent Analysis (by Year), January 2019-December 2022
  • Figure 18: Nucleic Acid Sample Preparation Market, Patent Analysis (by Country), January 2019-December 2022
  • Figure 19: Nucleic Acid Sample Preparation Market, Patent Analysis (by Region), January 2019-December 2022
  • Figure 20: Virus Testing Workflow
  • Figure 21: NGS Applications in Laboratories during COVID-19
  • Figure 22: Nucleic Acid Sample Preparation Market - Market Dynamics
  • Figure 23: Techniques for Nucleic Acid Extraction/Isolation
  • Figure 24: Benefits of Automated Nucleic Acid Sample Preparation
  • Figure 25: Share of Key Developments, January 2019-November 2022
  • Figure 26: Share of Synergistic Activities (by Company), January 2019-November 2022
  • Figure 27: Number of Business Expansion Activities (by Company), January 2019-November 2022
  • Figure 28: Number of Product Launches (by Company), January 2019-November 2022
  • Figure 29: Market Share Analysis of the Global Nucleic Acid Sample Preparation Market (by Company), 2021
  • Figure 30: Nucleic Acid Sample Preparation Market (by Region)
  • Figure 31: Nucleic Acid Sample Preparation Market (by Region), $Million, 2021-2032
  • Figure 32: Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 33: Europe Nucleic Acid Sample Preparation Market (by Country), 2021 and 2032
  • Figure 34: Germany Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 35: France Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 36: U.K. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 37: Italy Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 38: Spain Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 39: Rest-of-Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
  • Figure 40: Total Number of Companies Profiled
  • Figure 41: Endress+Hauser Group Services AG (Analytik Jena GmbH): Product Portfolio
  • Figure 42: Endress+Hauser Group Services AG (Analytik Jena GmbH): Overall Financials, $Million, 2019-2021
  • Figure 43: Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Segment), $Million, 2019-2021
  • Figure 44: Endress+Hauser Group Services AG (Analytik Jena GmbH): R&D Expenditure, $Million, 2019-2021
  • Figure 45: Eppendorf SE: Product Portfolio
  • Figure 46: Eppendorf SE: Overall Financials, $Million, 2019-2021
  • Figure 47: Eppendorf SE: Revenue (by Segment), $Million, 2019-2021
  • Figure 48: Eppendorf SE: Revenue (by Region), $Million, 2019-2021
  • Figure 49: Eppendorf SE: R&D Expenditure, $Million, 2019-2021
  • Figure 50: F. Hoffmann-La Roche Ltd: Product Portfolio
  • Figure 51: F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2019-2021
  • Figure 52: F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2019-2021
  • Figure 53: F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2019-2021
  • Figure 54: F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2019-2021
  • Figure 55: Merck KGaA: Product Portfolio
  • Figure 56: Merck KGaA: Overall Financials, $Million, 2019-2021
  • Figure 57: Merck KGaA: Revenue (by Segment), $Million, 2019-2021
  • Figure 58: Merck KGaA: Revenue (by Region), $Million, 2019-2021
  • Figure 59: Merck KGaA: R&D Expenditure, $Million, 2019-2021
  • Figure 60: QIAGEN: Product Portfolio
  • Figure 61: QIAGEN: Overall Financials, 2019-2021
  • Figure 62: QIAGEN: Revenue (by Segment), 2019-2021
  • Figure 63: QIAGEN: Revenue (by Region), 2019-2021
  • Figure 64: QIAGEN: R&D Expenditure, 2019-2021
  • Figure 65: Tecan Trading AG: Product Portfolio
  • Figure 66: Tecan Trading AG: Overall Financials, 2019-2021
  • Figure 67: Tecan Trading AG: Revenue (by Segment), 2019-2021
  • Figure 68: Tecan Trading AG: Revenue (by Region), 2019-2021
  • Figure 69: Tecan Trading AG: R&D Expenditure, 2019-2021

List of Tables

  • Table 1: Impact Analysis of Market Drivers, Restraints, and Opportunities on the Nucleic Acid Sample Preparation Market
  • Table 2: Industry Participants' Landscape in the Nucleic Acid Sample Preparation Market
  • Table 3: Cost of Automated Workstations